Skip to main contentSkip to navigation
Sirius Investors
Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for PSCBF. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
1.60M
91311476.0x increase over period
CAGR: +9644.72%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
1.86M
N/A over period

Market Cap History

Investor Valuation Insights

As of Nov 30, 2025

EV/EBITDA

Distorted

-8.11x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

264.20K

EV is +16.6% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +129385659.7 pp vs earliest data

Additional Multiples

EV/Sales: 4.82x

Net Debt/EBITDA: -0.63x

Share count change in dataset: +123.45%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Nov 30, 20231.60M1.86M$0.0723.53M
Nov 30, 20221.36M1.65M$0.1013.11M
Nov 30, 20219.28K17.05K$0.0012.70M
Nov 30, 2020
Nov 30, 2019

Enterprise Value Analysis

Price Change (Nov 2022 to Nov 2023)

The stock price has decreased from Nov 2022 to Nov 2023.
-34.61%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
2296.01

Risk-Adjusted Return

The stock offers a reasonable return for its level of risk.
0.61

Market Cap Change (Nov 2022 to Nov 2023)

The company's market capitalization has increased from Nov 2022 to Nov 2023.
+17.36%

Enterprise Value Change (Nov 2022 to Nov 2023)

The company's enterprise value has increased from Nov 2022 to Nov 2023, suggesting growth in the company's total economic value.
+12.43%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
9644.72%